Loading...

ACB - Aurora Cannabis Inc.

Analyst Upgrade Signal for 06-24-2022
Analyst Upgrade Signal: ACB from Neutral to Overweight by Cantor Fitzgerald
Price Target: $--



Stock Signal Information


Signal

Analyst Upgrade Stock
Report Date: 06-24-2022
Symbol: ACB - Aurora Cannabis Inc.
Sector: Healthcare
Industry: Drug Manufacturers—Specialty & Generic
Analyst Upgrade Signal: ACB from Neutral to Overweight by Cantor Fitzgerald
Price Target: $--

  ACB Technical Chart

Company Contact

Aurora Cannabis Inc. (ACB)
500-10355 Jasper Ave NW
Edmonton, ALBERTA T5J 1Y6
Phone: 16043625207
Website: http://www.auroramj.com
CEO: Mr. Michael Singer


Company Profile

Aurora Cannabis Inc. produces and distributes medical cannabis products worldwide. It is vertically integrated and horizontally diversified across various segments of the cannabis value chain, including facility engineering and design, cannabis breeding, genetics research, production, derivatives, high value-add product development, home cultivation, wholesale, and retail distribution. The company produces various strains of dried cannabis, cannabis oil and capsules, and topical kits for medical patients. It also sells vaporizers; consumable vaporizer accessories, including valves, screens, etc.; and herb mills for using CanniMed herbal cannabis products, as well as grinders and vaporizer lockable containers. In addition, the company engages in the development of medical cannabis products at various stages of development, including oral, topical, edible, and inhalable products; and operation of CanvasRX, a network of cannabis counseling and outreach centers. Further, it provides patient counselling services; design and construction services; and cannabis analytical product testing services. The company's brand portfolio includes Aurora, Aurora Drift, San Rafael '71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler, Woodstock, and ROAR Sports. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.